Stockscreener 앱 받기
10.96
0.09%
0.01
시장 영업 전:
9.01
-1.95
-17.79%
전일 마감가:
$10.95
열려 있는:
$11.07
하루 거래량:
72,948
Relative Volume:
0.74
시가총액:
$940.61M
수익:
$106.66M
순이익/손실:
$15.16M
주가수익비율:
117.22
EPS:
0.0935
순현금흐름:
$6.37M
1주 성능:
+4.18%
1개월 성능:
-1.62%
6개월 성능:
-27.70%
1년 성능:
-41.37%
1일 변동 폭
$10.61
$11.36
1주일 범위
$10.52
$11.36
52주 변동 폭
$8.26
$26.37
Gyre Therapeutics Inc Stock (GYRE) Company Profile
명칭
Gyre Therapeutics Inc
전화
(619) 949-3681
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
10.96 | 940.61M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-29 | 재개 | Stephens | Overweight |
| 2021-02-10 | 개시 | Piper Sandler | Overweight |
| 2020-05-21 | 개시 | Raymond James | Outperform |
| 2019-01-04 | 개시 | Oppenheimer | Outperform |
| 2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 개시 | Chardan Capital Markets | Buy |
| 2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
| 2016-06-30 | 개시 | Rodman & Renshaw | Buy |
모두보기
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 - MSN
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 By Investing.com - Investing.com Australia
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in December - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock - MSN
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics president Songjiang Ma sells $11,156 in stock By Investing.com - Investing.com South Africa
Songjiang Ma Sells 1,057 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics president Songjiang Ma sells $11,156 in stock - Investing.com
Barclays PLC Has $116,000 Stock Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells $22,336 in stock - Investing.com
Geode Capital Management LLC Has $3.81 Million Stock Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Leadership Changes at Gyre Therapeutics Amid Strategic Shift - TipRanks
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 3.2%Time to Sell? - MarketBeat
Gyre Therapeutics Reshapes Leadership: Appoints String Capital's Ping Zhang as Lead Director - StockTitan
Gyre Therapeutics president Ma Songjiang sells $49,600 in stock By Investing.com - Investing.com Australia
State Street Corp Grows Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells $49,600 in stock - Investing.com
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.4% Following Insider Selling - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.4% After Insider Selling - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $50,553 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $25,400.00 in Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $50,553 in stock - Investing.com India
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $48,399 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $48,399 in stock - Investing.com India
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Fmr LLC Takes $47,000 Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 3%What's Next? - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $43,440 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $21,640.00 in Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $43,440 in stock - Investing.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpHere's Why - MarketBeat
Gyre therapeutics president Ma Songjiang sells $44,851 in stock By Investing.com - Investing.com Australia
Gyre therapeutics president Ma Songjiang sells $44,851 in stock - Investing.com
Gyre Therapeutics Inc (GYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):